Molecular Quality Controls Market Product (Independent Control, Instrument Specific Control (PCR, DNA Sequencing), Application (Infectious Disease Diagnostics), Analyte type, End User (Hospitals, Diagnostic Lab), Region- Global Forecast to 2028

Abstract
The global molecular quality controls market is projected to reach USD 0.3 billion by 2028 from USD 0.2 billion in 2023, at a CAGR of 6.6% during the forecast period. Growth in this market is primarily driven by the increasing government funding for genomic projects, increasing demand for personalized medicines and declining costs of sequencing procedures, and increasing prevalence of infectious diseases, cancer, and genetic diseases. However, the additional costs involved in the quality control process and budget constraints in hospitals and laboratories, and the unfavorable reimbursement scenario for molecular tests are the major factors that are expected to restrain the growth of this market during the forecast period.

The independent controls segment has accounted for the biggest share of the market during the forecast period

By product, the molecular quality controls market is segmented into independent controls and instrument-specific controls. The independent controls segment accounted for the biggest share of the global molecular quality controls market in 2022. The increasing use of third-party independent quality controls is responsible for the large share of this segment.

The single-analyte controls has accounted for the biggest share of the market during the forecast period.

By analyte type, the molecular quality controls market is divided into single-analyte controls and multi-analyte controls. Single-analyte controls accounted for the biggest share of the molecular quality controls market in 2022. Factors such as the significant use of singleplex assays in hospitals, and low risk of cross-reactivity are responsible for the large share of this segment.

The infectious disease diagnostic segment accounted for the biggest share of the market in 2022

By application, the molecular quality controls market is divided into infectious disease diagnostics, genetic testing, oncology testing, and other applications (including neurology disease testing, , DNA fingerprinting, tissue typing, microbiology and cardiovascular disease testing). The infectious disease diagnostics segment accounted for the biggest share of the global molecular quality controls market in 2022. The significant increase in the prevalence of infectious diseases is responsible for the large share of this segment.

The diagnostic laboratories segment accounted for the biggest share of the market in 2022

By end users, the molecular quality controls market is segmented into academic & research institutes, diagnostic laboratories, IVD manufacturers & CROs, hospitals and other end users (home health agencies, blood banks, nursing homes, and local public health laboratories). The diagnostic laboratories segment accounted for the biggest share of the molecular quality controls market in 2022. The growing number of laboratory tests performed in diagnostic laboratories is responsible for the large share of this segment.

North America accounted for the largest share of the Molecular Quality Controls market in 2022

Based on region, the molecular quality controls market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the molecular quality controls market in 2022. The large share of this regional segment is mainly due to the developed healthcare system in the US and Canada, the presence of many leading molecular quality control product manufacturers, and easy accessibility to technologically advanced products in North America.

The break up of the profile of primary participants in the molecular Quality controls market:
•By Company Type: Tier 1- 35%, Tier 2- 45%, and Tier 3-20%
•By Designation: C-level Executives- 35%, Directors- 25% , and Others- 40%.
•By Region: North America - 40%, Europe – 30%, APAC –20%, Latin America – 5%,Middle East & Africa–5%

Key players in the molecular quality controls market
The key players operating in the molecular quality controls market include Microbiologics, Inc. (US), Steck, Inc. (US), Bio-Rad Laboratories, Inc. (US), Anchor Molecular (US), Thermo Fisher Scientific, Inc. (US), Randox Laboratories Ltd. (UK), LGC Limited (UK), Abbott Laboratories (US), Fortress Diagnostics (UK), SERO AS (Norway), Anchor Molecular (US), Vircell S.L. (Spain), Ortho Clinical Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Microbix Biosystems Inc. (Canada), Molbio Diagnostics Pvt. Ltd. (India), QuidelOrthoCorporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix, LLC (US), Qnostics (UK), Bio-Techne Corporation (US), Helena Laboratories Corporation (US), SpeeDx Pty. Ltd. (Australia), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain).

Research Coverage:
The report analyzes the molecular quality controls market and aims at estimating the market size and future growth potential of this market based on various segments such as product, analyte type, application, and end user. The report also includes a product portfolio matrix of various molecular quality controls products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, service offerings, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
•Analysis of key drivers (growing adoption of third-party quality controls, increasing investments in genomics, growing preference for personalized medicines, rising demand for external quality assessment support, and increasing prevalence of infectious diseases and cancer), restraints (high costs and budget constraints in clinical laboratories, and unfavorable reimbursement for molecular tests), opportunities (rising demand for multi-analyte controls, and growth opportunities in emerging countries), and challenges (changing regulatory framework)
•Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the global molecular quality controls market
•Market Development: Comprehensive information on the lucrative emerging markets by product, analyte type, application, and end user.
•Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global molecular quality controls market.
•Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global molecular quality controls market. This report also helps stakeholders understand the pulse of the molecular quality controls market and provides them information on key market drivers, restraints, challenges, and opportunities.

Content
Table of Contents

1INTRODUCTION24
1.1STUDY OBJECTIVES24
1.2MARKET DEFINITION24
1.2.1INCLUSIONS AND EXCLUSIONS24
1.3MARKET SCOPE25
1.3.1MARKETS COVERED25
1.3.2YEARS CONSIDERED26
1.4CURRENCY CONSIDERED26
TABLE 1STANDARD CURRENCY CONVERSION RATES26
1.5STUDY LIMITATIONS27
1.6STAKEHOLDERS27
1.7SUMMARY OF CHANGES27
1.8RECESSION IMPACT28
2RESEARCH METHODOLOGY29
2.1RESEARCH DATA29
FIGURE 1RESEARCH DESIGN29
2.2RESEARCH DESIGN29
2.2.1SECONDARY RESEARCH29
2.2.1.1Key data from secondary sources30
2.2.2PRIMARY RESEARCH31
FIGURE 2PRIMARY SOURCES31
2.2.2.1Key data from primary sources32
FIGURE 3INSIGHTS FROM INDUSTRY EXPERTS33
2.2.2.2Breakdown of primaries33
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION33
2.3MARKET SIZE ESTIMATION34
FIGURE 5MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS35
FIGURE 6MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHARE ANALYSIS36
FIGURE 7MARKET SIZE ESTIMATION: PARENT MARKET37
FIGURE 8CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS38
FIGURE 9MOLECULAR QUALITY CONTROLS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES39
2.4MARKET BREAKDOWN AND DATA TRIANGULATION41
FIGURE 10DATA TRIANGULATION METHODOLOGY41
2.5MARKET SHARE ANALYSIS42
2.6STUDY ASSUMPTIONS42
2.7RISK ASSESSMENT42
TABLE 2MOLECULAR QUALITY CONTROLS MARKET: RISK ASSESSMENT ANALYSIS42
2.8MARKET LIMITATIONS43
2.8.1METHODOLOGY-RELATED LIMITATIONS43
2.8.2SCOPE-RELATED LIMITATIONS43
2.9RECESSION IMPACT ANALYSIS43
3EXECUTIVE SUMMARY45
FIGURE 11MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)45
FIGURE 12MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2023 VS. 2028 (USD MILLION)46
FIGURE 13MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)46
FIGURE 14MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)47
FIGURE 15GEOGRAPHICAL SNAPSHOT OF MOLECULAR QUALITY CONTROLS MARKET48
4PREMIUM INSIGHTS49
4.1MOLECULAR QUALITY CONTROLS MARKET OVERVIEW49
FIGURE 16RISING PREVALENCE OF INFECTIOUS DISEASES AND CANCER TO DRIVE MARKET49
4.2MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT50
FIGURE 17INSTRUMENT-SPECIFIC CONTROLS SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD50
4.3ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION AND COUNTRY51
FIGURE 18INFECTIOUS DISEASE DIAGNOSTICS SEGMENT IN JAPAN ACCOUNTED FOR LARGEST MARKET SHARE IN 202251
4.4MOLECULAR QUALITY CONTROLS MARKET: GEOGRAPHICAL MIX52
FIGURE 19CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD52
4.5MOLECULAR QUALITY CONTROLS MARKET: DEVELOPED MARKETS VS. EMERGING MARKETS53
FIGURE 20EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD53
5MARKET OVERVIEW54
5.1INTRODUCTION54
FIGURE 21MOLECULAR QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES54
5.1.1DRIVERS55
5.1.1.1Rising number of accredited clinical laboratories55
FIGURE 22NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (MAY 2023)55
5.1.1.2Growing adoption of third-party quality controls56
TABLE 3THIRD-PARTY INDEPENDENT QUALITY CONTROLS OFFERED BY KEY COMPANIES56
5.1.1.3Increasing investments in genomics57
TABLE 4GOVERNMENT FUNDING INITIATIVES FOR GENOMICS RESEARCH (2019−2022)57
5.1.1.4Growing preference for personalized medicine58
TABLE 5US: NUMBER OF PERSONALIZED MEDICINES AVAILABLE (2008–2020)59
FIGURE 23FDA-APPROVED PERSONALIZED MEDICINES (2015–2022)59
FIGURE 24COST OF SEQUENCING PROCEDURES (2016−2021)60
5.1.1.5Increasing prevalence of infectious diseases and cancer60
FIGURE 25GLOBAL CANCER INCIDENCE, 2018–2040 (MILLION)61
5.1.1.6Rising demand for external quality assessment support62
5.1.2RESTRAINTS62
5.1.2.1Budgetary constraints in clinical laboratories62
5.1.2.2Unfavorable reimbursements for molecular tests63
5.1.3OPPORTUNITIES63
5.1.3.1Rising demand for multi-analyte controls63
5.1.3.2Growth opportunities in emerging markets64
5.1.4CHALLENGES64
5.1.4.1Stringent regulatory requirements for IVD products64
5.2INDUSTRY TRENDS65
5.2.1LYOPHILIZED/FREEZE-DRIED CONTROLS65
TABLE 6LYOPHILIZED OR FREEZE-DRIED QUALITY CONTROLS OFFERED BY KEY COMPANIES65
5.3PRICING ANALYSIS66
TABLE 7PRICE RANGE FOR MOLECULAR QUALITY CONTROLS, BY TYPE (2022)66
5.4VALUE CHAIN ANALYSIS66
FIGURE 26VALUE CHAIN ANALYSIS67
5.5SUPPLY CHAIN ANALYSIS67
FIGURE 27SUPPLY CHAIN ANALYSIS68
5.6ECOSYSTEM ANALYSIS68
FIGURE 28MOLECULAR QUALITY CONTROLS MARKET: ECOSYSTEM MARKET MAP69
5.7PORTER’S FIVE FORCES ANALYSIS69
TABLE 8MOLECULAR QUALITY CONTROLS MARKET: PORTER’S FIVE FORCES ANALYSIS69
5.7.1THREAT OF NEW ENTRANTS70
5.7.2THREAT OF SUBSTITUTES70
5.7.3BARGAINING POWER OF BUYERS70
5.7.4BARGAINING POWER OF SUPPLIERS70
5.7.5INTENSITY OF COMPETITIVE RIVALRY71
 
5.8TRADE ANALYSIS71
5.8.1TRADE ANALYSIS FOR DIAGNOSTIC & LABORATORY REAGENTS71
5.8.1.1Import data for diagnostic & laboratory reagents, by country, 2018–2021 (USD million)71
5.8.1.2Export data for diagnostic & laboratory reagents, by country, 2018–2021 (USD million)71
5.9TARIFF AND REGULATORY ANALYSIS72
5.9.1REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS72
TABLE 9LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS72
5.9.2REGULATORY ANALYSIS72
5.9.2.1North America72
5.9.2.1.1US72
TABLE 10US FDA: MEDICAL DEVICE CLASSIFICATION73
TABLE 11US: CLASSIFICATION OF QUALITY CONTROL MATERIAL73
TABLE 12US: CLASSIFICATION, TIME, AND COMPLEXITY OF REGISTRATION73
5.9.2.1.2Canada74
TABLE 13CANADA: CLASSIFICATION OF IVD PRODUCTS74
TABLE 14CANADA: CLASSIFICATION, TIME, AND COMPLEXITY OF REGISTRATION74
5.9.2.2Europe75
TABLE 15EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES75
5.9.2.3Asia Pacific75
5.9.2.3.1Japan75
5.9.2.3.2China76
5.9.2.3.3India76
5.10PATENT ANALYSIS76
5.10.1INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS76
FIGURE 29MOLECULAR QUALITY CONTROLS MARKET: TOP PATENT OWNERS AND APPLICANTS (JANUARY 2011–JUNE 2023)77
FIGURE 30MOLECULAR QUALITY CONTROLS MARKET: TOP APPLICANT JURISDICTIONS (JANUARY 2011–JUNE 2023)78
5.10.2PATENT PUBLICATION TRENDS78
FIGURE 31MOLECULAR QUALITY CONTROLS MARKET: PATENT ANALYSIS (JANUARY 2011–FEBRUARY 2023)78
TABLE 16MOLECULAR QUALITY CONTROLS MARKET: LIST OF PATENTS/PATENT APPLICATIONS (2020–2023)79
5.11KEY CONFERENCES AND EVENTS80
TABLE 17MOLECULAR QUALITY CONTROLS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023–202480
5.12KEY STAKEHOLDERS AND BUYING CRITERIA81
5.12.1KEY STAKEHOLDERS IN BUYING PROCESS81
FIGURE 32INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MOLECULAR QUALITY CONTROL PRODUCTS81
TABLE 18INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MOLECULAR QUALITY CONTROL PRODUCTS (%)81
5.12.2BUYING CRITERIA82
FIGURE 33KEY BUYING CRITERIA FOR MOLECULAR QUALITY CONTROL PRODUCTS82
TABLE 19KEY BUYING CRITERIA FOR MOLECULAR QUALITY CONTROL PRODUCTS82
5.13TRENDS AND DISRUPTIONS AFFECTING CUSTOMERS’ BUSINESSES83
FIGURE 34MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHIFT83
6MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT84
6.1INTRODUCTION85
TABLE 20QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS OFFERED BY KEY MARKET PLAYERS85
TABLE 21MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)86
6.2INDEPENDENT CONTROLS86
6.2.1MINIMIZED LOT CROSSOVERS FOR LABORATORIES AND LOW OPERATION COSTS TO DRIVE MARKET86
TABLE 22INDEPENDENT MOLECULAR QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS86
TABLE 23INDEPENDENT MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)87
6.3INSTRUMENT-SPECIFIC CONTROLS88
TABLE 24INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS88
TABLE 25INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)89
TABLE 26INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)89
6.3.1POLYMERASE CHAIN REACTION90
6.3.1.1Rising applications in proteomics and genomics to propel market90
TABLE 27INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR PCR, BY COUNTRY, 2021–2028 (USD MILLION)91
6.3.2DNA SEQUENCING AND NGS91
6.3.2.1Increasing advancements in sequencing technologies to drive market91
TABLE 28INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR DNA SEQUENCING & NGS, BY COUNTRY, 2021–2028 (USD MILLION)92
6.3.3OTHER TECHNOLOGIES92
TABLE 29INSTRUMENT-SPECIFIC MOLECULAR QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION)93
7MOLECULAR QUALITY CONTROL MARKET, BY ANALYTE TYPE94
7.1INTRODUCTION95
TABLE 30MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)95
7.2SINGLE-ANALYTE CONTROLS95
7.2.1RISING ADOPTION OF SINGLEPLEX ASSAYS IN HOSPITALS TO SUPPORT MARKET GROWTH95
TABLE 31SINGLE-ANALYTE CONTROLS OFFERED BY KEY MARKET PLAYERS96
TABLE 32SINGLE-ANALYTE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)96
7.3MULTI-ANALYTE CONTROLS97
7.3.1GROWING PREFERENCE FOR COST-EFFECTIVE CONTROLS TO DRIVE MARKET97
TABLE 33MULTI-ANALYTE CONTROLS OFFERED BY KEY MARKET PLAYERS97
TABLE 34MULTI-ANALYTE MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)98
8MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION99
8.1INTRODUCTION100
TABLE 35MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)100
8.2INFECTIOUS DISEASE DIAGNOSTICS100
8.2.1RISING INCIDENCE OF INFLUENZA, TB, AND HIV TO DRIVE MARKET100
TABLE 36NUMBER OF COVID-19 CASES, BY COUNTRY (FEBRUARY 2023)101
TABLE 37MOLECULAR QUALITY CONTROLS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2021–2028 (USD MILLION)102
8.3ONCOLOGY TESTING103
8.3.1GROWING FOCUS ON PERSONALIZED MEDICINE TO PROPEL MARKET103
TABLE 38INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)104
TABLE 39MOLECULAR QUALITY CONTROLS MARKET FOR ONCOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)105
8.4GENETIC TESTING105
8.4.1ABILITY TO DIAGNOSE RARE DISEASES TO SUPPORT MARKET GROWTH105
TABLE 40MOLECULAR QUALITY CONTROLS MARKET FOR GENETIC TESTING, BY COUNTRY, 2021–2028 (USD MILLION)106
8.5OTHER APPLICATIONS106
TABLE 41MOLECULAR QUALITY CONTROLS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)107
9MOLECULAR QUALITY CONTROLS MARKET, BY END USER108
9.1INTRODUCTION109
TABLE 42MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)109
9.2DIAGNOSTIC LABORATORIES109
9.2.1INCREASING NUMBER OF ACCREDITED DIAGNOSTIC LABORATORIES TO DRIVE MARKET109
TABLE 43MOLECULAR QUALITY CONTROLS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)111
9.3HOSPITALS111
9.3.1ABILITY TO CONDUCT LARGE VOLUME OF DIAGNOSTIC PROCEDURES TO PROPEL MARKET111
TABLE 44MOLECULAR QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)113
9.4IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS113
9.4.1ADVANCEMENTS IN MOLECULAR TECHNOLOGIES TO SUPPORT MARKET GROWTH113
TABLE 45MOLECULAR QUALITY CONTROLS MARKET FOR IVD MANUFACTURERS AND CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021–2028 (USD MILLION)114
9.5ACADEMIC & RESEARCH INSTITUTES114
9.5.1RISING FOCUS ON ACCURATE RESEARCH RESULTS TO DRIVE MARKET114
TABLE 46MOLECULAR QUALITY CONTROLS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)115
9.6OTHER END USERS115
TABLE 47MOLECULAR QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)116
10MOLECULAR QUALITY CONTROLS MARKET, BY REGION117
10.1INTRODUCTION118
TABLE 48MOLECULAR QUALITY CONTROLS MARKET, BY REGION, 2021–2028 (USD MILLION)118
10.2NORTH AMERICA118
FIGURE 35NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT119
TABLE 49NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)119
TABLE 50NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)120
TABLE 51NORTH AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)120
TABLE 52NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)120
TABLE 53NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)121
TABLE 54NORTH AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)121
10.2.1US121
10.2.1.1Growing number of accredited clinical laboratories to drive market121
FIGURE 36US: NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (MAY 2023)122
TABLE 55US: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)123
TABLE 56US: INSTRUMENT-SPECIFIC CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)123
TABLE 57US: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)123
TABLE 58US: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)124
TABLE 59US: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)124
10.2.2CANADA124
10.2.2.1Rising funding investments for genomic research to propel market124
TABLE 60CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)125
TABLE 61CANADA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)126
TABLE 62CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)126
TABLE 63CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)126
TABLE 64CANADA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)127
10.2.3NORTH AMERICA: RECESSION IMPACT127
10.3EUROPE127
TABLE 65EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)128
TABLE 66EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)128
TABLE 67EUROPE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)129
TABLE 68EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)129
TABLE 69EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)129
TABLE 70EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)130
10.3.1GERMANY130
10.3.1.1Rising volume of diagnostic tests in clinical settings to drive market130
TABLE 71GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)130
TABLE 72GERMANY: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)131
TABLE 73GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)131
TABLE 74GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)131
TABLE 75GERMANY: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)132
10.3.2UK132
10.3.2.1Growth in life sciences industry to propel market132
TABLE 76UK: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)133
TABLE 77UK: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)133
TABLE 78UK: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)133
TABLE 79UK: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)134
TABLE 80UK: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)134
10.3.3FRANCE134
10.3.3.1Rising prevalence of cancer and endocrine disorders to support market growth134
TABLE 81FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)135
TABLE 82FRANCE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)135
TABLE 83FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)135
TABLE 84FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)136
TABLE 85FRANCE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)136
10.3.4ITALY136
10.3.4.1Rising incidence of age-associated chronic ailments to support market growth136
TABLE 86ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)137
TABLE 87ITALY: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)137
TABLE 88ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)137
TABLE 89ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)138
TABLE 90ITALY: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)138
10.3.5SPAIN138
10.3.5.1Increasing demand for prenatal and genetic testing to support market growth138
TABLE 91SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)139
TABLE 92SPAIN: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)139
TABLE 93SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)140
TABLE 94SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)140
TABLE 95SPAIN: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)140
10.3.6RUSSIA141
10.3.6.1Growing acceptance of molecular diagnostics-based personalized medicine to propel market141
TABLE 96RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)141
TABLE 97RUSSIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)141
TABLE 98RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)142
TABLE 99RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)142
TABLE 100RUSSIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)142
10.3.7REST OF EUROPE143
TABLE 101REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)143
TABLE 102REST OF EUROPE: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)143
TABLE 103REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)144
TABLE 104REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)144
TABLE 105REST OF EUROPE: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)144
10.3.8EUROPE: RECESSION IMPACT145
10.4ASIA PACIFIC145
FIGURE 37ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET SNAPSHOT146
TABLE 106ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)147
TABLE 107ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)147
TABLE 108ASIA PACIFIC: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)147
TABLE 109ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)148
TABLE 110ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)148
TABLE 111ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)148
10.4.1JAPAN149
10.4.1.1Established healthcare system and rising demand for high-quality IVD tests to drive market149
TABLE 112JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)149
TABLE 113JAPAN: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)149
TABLE 114JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)150
TABLE 115JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)150
TABLE 116JAPAN: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)150
10.4.2CHINA151
10.4.2.1Rising R&D investments for advanced molecular tests to drive market151
TABLE 117CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)151
TABLE 118CHINA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)152
TABLE 119CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)152
TABLE 120CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)152
TABLE 121CHINA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)153
10.4.3INDIA153
10.4.3.1Rising need to secure NABL accreditations to support market growth153
FIGURE 38INDIA: INCREASING NUMBER OF LABORATORIES WITH NABL ACCREDITATIONS (2012–2020)154
TABLE 122INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)154
TABLE 123INDIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)155
TABLE 124INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)155
TABLE 125INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)155
TABLE 126INDIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)156
10.4.4AUSTRALIA156
10.4.4.1High prevalence of infectious diseases to fuel market156
TABLE 127AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)156
TABLE 128AUSTRALIA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)157
TABLE 129AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)157
TABLE 130AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)157
TABLE 131AUSTRALIA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)158
10.4.5REST OF ASIA PACIFIC158
TABLE 132REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)158
TABLE 133REST OF ASIA PACIFIC: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)159
TABLE 134REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)159
TABLE 135REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)159
TABLE 136REST OF ASIA PACIFIC: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)160
10.4.6ASIA PACIFIC: RECESSION IMPACT160
10.5LATIN AMERICA160
TABLE 137LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)161
TABLE 138LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)161
TABLE 139LATIN AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)161
TABLE 140LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)162
TABLE 141LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)162
TABLE 142LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, ‘ 2021–2028 (USD MILLION)162
10.5.1BRAZIL163
10.5.1.1Improving healthcare infrastructure to support market growth163
TABLE 143BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)163
TABLE 144BRAZIL: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)163
TABLE 145BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)164
TABLE 146BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)164
TABLE 147BRAZIL: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)164
10.5.2MEXICO165
10.5.2.1Improving accessibility and affordability of healthcare services to support market growth165
TABLE 148MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)165
TABLE 149MEXICO: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)165
TABLE 150MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)166
TABLE 151MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)166
TABLE 152MEXICO: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)166
10.5.3REST OF LATIN AMERICA167
TABLE 153REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)167
TABLE 154REST OF LATIN AMERICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)167
TABLE 155REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)167
TABLE 156REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)168
TABLE 157REST OF LATIN AMERICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)168
10.5.4LATIN AMERICA: RECESSION IMPACT168
10.6MIDDLE EAST & AFRICA169
10.6.1GOVERNMENT INITIATIVES TO IMPROVE HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH169
10.6.2MIDDLE EAST & AFRICA: RECESSION IMPACT169
TABLE 158MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)169
TABLE 159MIDDLE EAST & AFRICA: INSTRUMENT-SPECIFIC MOLECULAR CONTROLS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)170
TABLE 160MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY ANALYTE TYPE, 2021–2028 (USD MILLION)170
TABLE 161MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)170
TABLE 162MIDDLE EAST & AFRICA: MOLECULAR QUALITY CONTROLS MARKET, BY END USER, 2021–2028 (USD MILLION)171
11COMPETITIVE LANDSCAPE172
11.1OVERVIEW172
11.2STRATEGIES ADOPTED BY KEY PLAYERS173
11.3REVENUE SHARE ANALYSIS OF LEADING MARKET PLAYERS174
FIGURE 39MOLECULAR QUALITY CONTROLS MARKET: REVENUE SHARE ANALYSIS OF LEADING PLAYERS174
11.4MARKET SHARE ANALYSIS175
FIGURE 40MOLECULAR QUALITY CONTROLS MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)175
TABLE 163MOLECULAR QUALITY CONTROLS MARKET: INTENSITY OF COMPETITIVE RIVALRY176
11.5COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)177
11.5.1STARS177
11.5.2EMERGING LEADERS177
11.5.3PERVASIVE PLAYERS178
11.5.4PARTICIPANTS178
FIGURE 41MOLECULAR QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)178
11.6COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)179
11.6.1PROGRESSIVE COMPANIES179
11.6.2STARTING BLOCKS179
11.6.3RESPONSIVE COMPANIES179
11.6.4DYNAMIC COMPANIES179
FIGURE 42MOLECULAR QUALITY CONTROLS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)180
11.7COMPANY FOOTPRINT ANALYSIS180
TABLE 164MOLECULAR QUALITY CONTROLS MARKET: COMPANY FOOTPRINT ANALYSIS181
TABLE 165MOLECULAR QUALITY CONTROLS MARKET: ANALYTE TYPE FOOTPRINT ANALYSIS182
TABLE 166MOLECULAR QUALITY CONTROLS MARKET: APPLICATION FOOTPRINT ANALYSIS183
TABLE 167MOLECULAR QUALITY CONTROLS MARKET: REGIONAL FOOTPRINT ANALYSIS184
TABLE 168MOLECULAR QUALITY CONTROLS MARKET: END USER FOOTPRINT ANALYSIS185
11.8COMPETITIVE SITUATION AND TRENDS186
11.8.1PRODUCT LAUNCHES & APPROVALS186
TABLE 169PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–JUNE 2023)186
11.8.2DEALS187
TABLE 170DEALS (JANUARY 2020–JUNE 2023)187
11.8.3OTHER DEVELOPMENTS187
TABLE 171OTHER DEVELOPMENTS (JANUARY 2020–JUNE 2023)188
12COMPANY PROFILES189
12.1KEY PLAYERS189
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
12.1.1LGC LIMITED189
TABLE 172LGC LIMITED: BUSINESS OVERVIEW189
FIGURE 43LCG LIMITED: COMPANY SNAPSHOT (2022)190
12.1.2THERMO FISHER SCIENTIFIC, INC.198
TABLE 173THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW198
FIGURE 44THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)199
12.1.3BIO-RAD LABORATORIES, INC.205
TABLE 174BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW205
FIGURE 45BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)206
12.1.4MICROBIOLOGICS, INC.209
TABLE 175MICROBIOLOGICS, INC.: BUSINESS OVERVIEW209
12.1.5ABBOTT LABORATORIES214
TABLE 176ABBOTT LABORATORIES: BUSINESS OVERVIEW214
FIGURE 46ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)215
12.1.6F. HOFFMANN-LA ROCHE LTD.218
TABLE 177F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW218
FIGURE 47F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)219
12.1.7ZEPTOMETRIX, LLC221
TABLE 178ZEPTOMETRIX, LLC: BUSINESS OVERVIEW221
12.1.8QUIDELORTHO CORPORATION226
TABLE 179QUIDELORTHO CORPORATION: BUSINESS OVERVIEW226
FIGURE 48QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022)227
12.1.9QNOSTICS229
TABLE 180QNOSTICS: BUSINESS OVERVIEW229
12.1.10MAINE MOLECULAR QUALITY CONTROLS, INC.232
TABLE 181MAINE MOLECULAR QUALITY CONTROLS, INC.: BUSINESS OVERVIEW232
12.1.11RANDOX LABORATORIES LTD.235
TABLE 182RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW235
12.1.12DANAHER CORPORATION238
TABLE 183DANAHER CORPORATION: BUSINESS OVERVIEW238
FIGURE 49DANAHER CORPORATION: COMPANY SNAPSHOT (2022)239
12.1.13BIO-TECHNE CORPORATION241
TABLE 184BIO-TECHNE CORPORATION: BUSINESS OVERVIEW241
FIGURE 50BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2022)242
12.1.14FORTRESS DIAGNOSTICS244
TABLE 185FORTRESS DIAGNOSTICS: BUSINESS OVERVIEW244
12.1.15MICROBIX BIOSYSTEMS246
TABLE 186MICROBIX BIOSYSTEMS: BUSINESS OVERVIEW246
FIGURE 51MICROBIX BIOSYSTEMS: COMPANY SNAPSHOT (2022)247
12.1.16GRIFOLS, S.A.251
TABLE 187GRIFOLS, S.A.: BUSINESS OVERVIEW251
FIGURE 52GRIFOLS, S.A.: COMPANY SNAPSHOT (2022)252
12.1.17ANCHOR MOLECULAR254
TABLE 188ANCHOR MOLECULAR: BUSINESS OVERVIEW254
12.1.18SPEEDX PTY. LTD.255
TABLE 189SPEEDX PTY. LTD.: BUSINESS OVERVIEW255
12.1.19SEEGENE INC.257
TABLE 190SEEGENE INC.: BUSINESS OVERVIEW257
FIGURE 53SEEGENE INC: COMPANY SNAPSHOT (2022)258
12.1.20HELENA LABORATORIES CORPORATION262
TABLE 191HELENA LABORATORIES CORPORATION: BUSINESS OVERVIEW262
12.2OTHER PLAYERS265
12.2.1SERO AS265
TABLE 192SERO AS: BUSINESS OVERVIEW265
12.2.2VIRCELL, S.L.267
TABLE 193VIRCELL, S.L.: BUSINESS OVERVIEW267
12.2.3STRECK LLC269
TABLE 194STRECK LLC.: BUSINESS OVERVIEW269
12.2.4SUN DIAGNOSTICS, LLC271
TABLE 195SUN DIAGNOSTICS, LLC: BUSINESS OVERVIEW271
12.2.5MOLBIO DIAGNOSTICS PVT. LTD.272
TABLE 196MOLBIO DIAGNOSTICS PVT. LTD.: BUSINESS OVERVIEW272
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13APPENDIX273
13.1DISCUSSION GUIDE273
13.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL277
13.3CUSTOMIZATION OPTIONS279
13.4RELATED REPORTS279
13.5AUTHOR DETAILS280